Type 4 phosphodiesterase inhibitors attenuate respiratory syncytial virus-induced airway hyper-responsiveness and lung eosinophilia.
about
Modulation of eotaxin formation and eosinophil migration by selective inhibitors of phosphodiesterase type 4 isoenzymeIdentification of common biological pathways and drug targets across multiple respiratory viruses based on human host gene expression analysisAnti-inflammatory effects of the novel inhaled phosphodiesterase type 4 inhibitor CHF6001 on virus-inducible cytokinesAttenuation of TNF production and experimentally induced inflammation by PDE4 inhibitor rolipram is mediated by MAPK phosphatase-1.Mitigation of chlorine lung injury by increasing cyclic AMP levelsReduction of influenza virus-induced lung inflammation and mortality in animals treated with a phosophodisestrase-4 inhibitor and a selective serotonin reuptake inhibitor.
P2860
Type 4 phosphodiesterase inhibitors attenuate respiratory syncytial virus-induced airway hyper-responsiveness and lung eosinophilia.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Type 4 phosphodiesterase inhib ...... iveness and lung eosinophilia.
@en
Type 4 phosphodiesterase inhib ...... iveness and lung eosinophilia.
@nl
type
label
Type 4 phosphodiesterase inhib ...... iveness and lung eosinophilia.
@en
Type 4 phosphodiesterase inhib ...... iveness and lung eosinophilia.
@nl
prefLabel
Type 4 phosphodiesterase inhib ...... iveness and lung eosinophilia.
@en
Type 4 phosphodiesterase inhib ...... iveness and lung eosinophilia.
@nl
P2093
P1476
Type 4 phosphodiesterase inhib ...... iveness and lung eosinophilia.
@en
P2093
P304
P407
P577
2000-08-01T00:00:00Z